APVO436

APVO436 · Aptevo Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for APVO436, covering 2025-05-11 to 2025-05-11. Get the full timeline:

Most recent: Clinical Trial Update: APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML [Phase 1]